Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_assertion type Assertion NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_head.
- NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_assertion wasGeneratedBy ECO_0000203 NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_provenance.
- NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_assertion wasDerivedFrom befree-2016 NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_provenance.
- NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_assertion SIO_000772 11223838 NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_provenance.
- NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_assertion evidence source_evidence_literature NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_provenance.
- NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_assertion description "[Loss of heterozygosity at the hMLH1 and hMSH2 gene loci were observed in 4% (1/25 informative cases) and 6.1% (2/33) of EHBD cancer cases, respectively; and in 11.1% (1/9) and 8.3% (1/12) of ampullary cancer cases, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309413.RAhY6DmuWRjLzbUH4MjoKmRF_uNwkZvMuL5YOrN122Wtg130_provenance.